WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tarsus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aziz MottiwalaChief Commercial Officer2025-06-0917,500$43.76
$765.80kSell
Bobak R. AzamianPresidentCEO and Board Chair2025-03-246,000$50.00
$300.00kSell
Dianne C. WhitfieldChief Human Resources Officer2025-03-202,137$50.11
$107.09kSell
Bryan WahlGeneral Counsel2025-03-203,084$50.11
$154.54kSell
Bobak R. AzamianPresidentCEO and Board Chair2025-03-208,534$50.11
$427.64kSell
Seshadri NeervannanChief Operating Officer2025-03-202,435$50.11
$122.02kSell
Jeffrey S. FarrowChief Financial Officer and Chief Strategy Officer2025-03-201,186$50.11
$59.43kSell
Aziz MottiwalaChief Commercial Officer2025-03-203,365$50.11
$168.62kSell
Aziz MottiwalaChief Commercial Officer2025-03-193,557$47.40
$168.60kSell
Bobak R. AzamianPresidentCEO and Board Chair2025-03-198,551$47.40
$405.32kSell

1 of 3

TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARS insiders and whales buy or sell their stock.

TARS Shareholders

What type of owners hold Tarsus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital IX LLC13.60%5,714,036$233.65MInsider
Rtw Investments LP7.89%3,316,032$135.59MInstitution
Blackrock Inc7.51%3,153,728$128.96MInstitution
Paradigm Biocapital Advisors LP6.21%2,610,197$106.73MInstitution
Jennison Associates LLC5.93%2,492,640$101.92MInstitution
Tang Capital Management LLC5.84%2,454,797$100.38MInstitution
Vanguard Group Inc5.30%2,226,595$91.05MInstitution
Rtw Investments LP4.79%2,013,601$82.34MInsider
Morgan Stanley4.79%2,012,777$82.30MInstitution
Horowitz Limited Partnership VIII4.73%1,987,105$81.25MInsider

1 of 3

TARS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARS72.75%27.25%Net SellingNet Selling
BEAM84.84%15.16%Net SellingNet Selling
IMCR95.30%4.33%Net BuyingNet Buying
CNTA90.18%9.82%Net SellingNet Buying
DYN79.63%20.37%Net SellingNet Selling
View Top Biotech Stocks

Tarsus Pharmaceuticals Stock Ownership FAQ

Who owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals (NASDAQ: TARS) is owned by 103.69% institutional shareholders, 38.84% Tarsus Pharmaceuticals insiders, and 0.00% retail investors. Vivo Capital IX LLC is the largest individual Tarsus Pharmaceuticals shareholder, owning 5.71M shares representing 13.60% of the company. Vivo Capital IX LLC's Tarsus Pharmaceuticals shares are currently valued at $233.65M.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.